Table 4 Characteristics of economic evaluations by publication period
1995–2000 (n = 88) No. (%) of studies | 2001–2005 (n = 107) No. (%) of studies | 1995–2005 (n = 195) No. (%) of studies | |
|---|---|---|---|
By Study Type | |||
Cost effectiveness (life years gained) | 41 (47) | 32 (30) | 73 (37) |
Cost effectiveness (clinical outcome) | 25 (28) | 28 (26) | 53 (27) |
Cost utility | 6 (7) | 32 (30) | 38 (20) |
Cost consequence | 11 (13) | 10 (9) | 21 (11) |
Cost minimization | 4 (5) | 3 (3) | 7 (4) |
Cost benefit | 1 (1) | 2 (2) | 3 (2) |
By Perspective | |||
Societal | 15 (17) | 23 (22) | 38 (20) |
Third Party Payer | 28 (32) | 38 (36) | 66 (34) |
Health care provider | 1 (1) | 3 (3) | 4 (2) |
Patient | 1 (1) | 1 (1) | 2 (1) |
Other* | 3 (3) | 1 (1) | 4 (2) |
Not stated | 40 (46) | 41 (38) | 81 (42) |
By Funding source | |||
Government | 20 (23) | 31 (29) | 51 (26) |
Industry | 22 (25) | 29 (27) | 51 (26) |
Foundation | 10 (11) | 5 (5) | 15 (8) |
Other* | 0 (0) | 7 (7) | 7 (4) |
Not stated | 36 (41) | 35 (33) | 71 (36) |